Let’s start up with the current stock price of NovaBay Pharmaceuticals Inc. (NBY), which is $0.52 to be very precise. The Stock rose vividly during the last session to $0.56 after opening rate of $0.56 while the lowest price it went was recorded $0.52 before closing at $0.55.Recently in News on September 29, 2021, NovaBay Pharmaceuticals to Hold Conference Call and Webcast With Slide Presentation Today to Discuss Acquisition of DERMAdoctor. NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that management will discuss its acquisition of DERMAdoctor on an investment community conference call and webcast with accompanying slide presentation today, Wednesday, September 29, 2021 beginning at 4:30 p.m. Eastern time. You can read further details here
NovaBay Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $1.7900 on 02/18/21, with the lowest value was $0.5204 for the same time period, recorded on 10/12/21.
NovaBay Pharmaceuticals Inc. (NBY) full year performance was -34.06%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, NovaBay Pharmaceuticals Inc. shares are logging -70.68% during the 52-week period from high price, and 1.92% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.51 and $1.79.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 908241 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the NovaBay Pharmaceuticals Inc. (NBY) recorded performance in the market was -24.69%, having the revenues showcasing -12.68% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 23.84M, as it employees total of 22 workers.
Market experts do have their say about NovaBay Pharmaceuticals Inc. (NBY)
During the last month, 1 analysts gave the NovaBay Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 0.6450, with a change in the price was noted -0.16. In a similar fashion, NovaBay Pharmaceuticals Inc. posted a movement of -23.39% for the period of last 100 days, recording 1,690,258 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for NBY is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical breakdown of NovaBay Pharmaceuticals Inc. (NBY)
Raw Stochastic average of NovaBay Pharmaceuticals Inc. in the period of last 50 days is set at 1.80%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 1.80%. In the last 20 days, the company’s Stochastic %K was 4.15% and its Stochastic %D was recorded 6.34%.
Bearing in mind the latest performance of NovaBay Pharmaceuticals Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -24.69%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -34.68%, alongside a downfall of -34.06% for the period of the last 12 months. The shares increased approximately by -7.91% in the 7-day charts and went up by -16.02% in the period of the last 30 days. Common stock shares were lifted by -12.68% during last recorded quarter.